Drug profile · INN
carvedilol
CARVEDILOL
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
carvedilol (CARVEDILOL) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 8637041
Secreted Campylobacter flaggella coregulated proteins as immunogens
granted -
US 8329141
Locoregional internal radionuclide ablation of abnormal tissues
granted -
US 8221764
Secreted campylobacter flagella coregulated proteins as immunogens
granted -
US 8124644
Carvedilol phosphate
granted -
US 8114900
Amorphous carvedilol dihydrogen phosphate
granted -
US 8022094
Carvedilol phosphate
granted -
US 7605274
Carvedilol
granted -
US 7598396
Crystalline solids of carvedilol and processes for their preparation
granted
Frequently asked questions
What is carvedilol?
carvedilol (CARVEDILOL) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for carvedilol?
CARVEDILOL is a marketed brand name for carvedilol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of carvedilol?
carvedilol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.